Equilibre
About:
Equilibre is a biopharmaceuticals corporation developing differentiated and novel therapeutic candidates.
Website: https://eqneuro.com/
Twitter/X: eqbiopharma
Description:
Equilibre is a biopharmaceuticals corporation developing differentiated and novel therapeutic candidates. Équilibre is founded upon advancing science to benefit patients. They are committed to delivering innovative treatments to millions of patients who experience conditions for which there are inadequate or nonexistent treatments.
Total Funding Amount:
$52.4M
Headquarters Location:
New York, New York, United States
Founded Date:
2020-06-01
Contact Email:
info(AT)eqneuro.com
Founders:
Samuel D. Waksal
Number of Employees:
11-50
Last Funding Date:
2022-12-01
IPO Status:
Private
Industries:
© 2025 bioDAO.ai